Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice

Cytokine

Volumn 12, Issue 9, 2000, Pages 1337-1347

  De Villiers, Willem J S ^a,b   Varilek, Gary W ^a,b   De Beer, Frederick C ^a,b   Guo, Jun Tao ^a   Kindy, Mark S ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

Amyloid; Colitis; Interleukin 2; Serum amyloid A; Serum amyloid P component

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; AMYLOID P COMPONENT; CONGO RED; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON ULCER; CONTROLLED STUDY; DESCENDING COLON; DISEASE SEVERITY; HEPATITIS; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LIVER DISEASE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN DISEASE;

ANIMALIA;

EID: 0033802840     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0716     Document Type: Article

References (40)

1. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
2. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
3. Immune responses in interleukin-2-deficient mice
4. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation
5. + T cells
6. Generalized autoimmune diseases in BALB/c mice with a genetically dependent interleukin-2 deficiency
7. T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice
8. Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene
9. + T cells are responsible for murine interleukin-2-deficient colitis
10. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice
11. Development of colonic adenocarcinomas in a mouse model of ulcerative colitis
12. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein
13. Biochemical evidence for the biphasic development of experimental amyloidosis
14. Murine model for human secondary amyloidosis: Genetic variability of the acute-phase serum protein SAA response to endotoxins and casein
15. Amyloid A gene family expression in different mouse tissues
16. Murine serum amyloid A3 is a high-density apolipoprotein and is secreted by macrophages
17. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits
18. Specific deposition of serum amyloid A protein 2 in the mouse
19. Amyloido-genesis. One serum amyloid A isotype is selectively removed from the circulation
20. Crohn's disease with amyloid A amyloidosis and nephrotic syndrome
21. Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis
22. Secondary amyloidosis in ulcerative colitis - Successful treatment with colchicine
23. AA amyloidosis in systemic lupus erythematosus: An unusual complication
24. Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein
25. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease
26. + TH1-like responses
27. Increased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice
28. Reduction in amyloid A amyloid formation in apolipoprotein-E deficient mice
29. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: Implications for Alzheimer's disease
30. Expression of rat serum amyloid A1 gene involves both C/EBP-like and NF-κB-like transcription factors
31. Phosphatidylinositol 3-kinase in interleukin 1 signaling
32. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
33. Anti-amyloid drugs: Potential in the treatment of diseases associated with aging
34. Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis
35. Structural prerequisites for serum amyloid A fibril formation
36. Mouse serum amyloid A protein: Complete amino acid sequence and mRNA analysis of a new isoform
37. Cytokine regulation of the mouse SAA gene family
38. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis
39. Interleukin-1 receptor antagonist: Role in biology
40. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel disease